Lv6
2170 积分 2021-11-11 加入
N-nitrosamine safety assessments - Current challenges
1小时前
待确认
Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices
13天前
已完结
Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies
13天前
已完结
Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies
13天前
已完结
Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities (NDSRIs)
13天前
已完结
A Consideration of the Extent That Tertiary Amines Can Form N-Nitroso Dialkylamines in Pharmaceutical Products
13天前
已完结
DNA Repair-Responsive Engineered Whole Cell Microbial Sensors for Sensitive and High-Throughput Screening of Genotoxic Impurities
13天前
已完结
Leveraging ICH M7 Control Options 3 and 4: Discussion and Clarification Using Industrial Case Studies
13天前
已完结
A Brief Review on Genotoxic impurities in Pharmaceuticals
13天前
已关闭
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)
16天前
已完结
皖公网安备34019202002308
